These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20969973)

  • 1. Pharmacoproteomics: a chess game on a protein field.
    D'Alessandro A; Zolla L
    Drug Discov Today; 2010 Dec; 15(23-24):1015-23. PubMed ID: 20969973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoproteomics in drug development.
    Witzmann FA; Grant RA
    Pharmacogenomics J; 2003; 3(2):69-76. PubMed ID: 12746732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of pharmacoproteomics in the development of personalized medicine.
    Jain KK
    Pharmacogenomics; 2004 Apr; 5(3):331-6. PubMed ID: 15102547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promises of biomarkers in drug development--a reality check.
    Marrer E; Dieterle F
    Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.
    Hu S; Yen Y; Ann D; Wong DT
    Drug Discov Today; 2007 Nov; 12(21-22):911-6. PubMed ID: 17993408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges of drug discovery for personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmaco-proteomic analysis: application of proteomic analysis to the discovery and development of new drugs].
    Chapal N; Laplanche M; Ribes G; Pau B; Garin J; Petit P
    J Soc Biol; 2002; 196(4):317-22. PubMed ID: 12645303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations.
    Nandal S; Burt T
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical biomarkers in drug discovery and development.
    Frank R; Hargreaves R
    Nat Rev Drug Discov; 2003 Jul; 2(7):566-80. PubMed ID: 12838269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in human disease proteomics].
    He FC; Wan JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):219-22. PubMed ID: 12905621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How molecular profiling could revolutionize drug discovery.
    Stoughton RB; Friend SH
    Nat Rev Drug Discov; 2005 Apr; 4(4):345-50. PubMed ID: 15789121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M; Stojnev S; Stefanovic V
    Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of LC/MS to proteomics studies: current status and future prospects.
    Chen G; Pramanik BN
    Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential proteomics of sperm: insights, challenges and future prospects.
    Tomar AK; Saraswat M; Chhikara N; Kumar S; Yadav VK; Sooch BS; Singh TP; Yadav S
    Biomark Med; 2010 Dec; 4(6):905-10. PubMed ID: 21133711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in fragment-based lead discovery.
    Schulz MN; Hubbard RE
    Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering the therapeutic potential of natural products with biomarker-guided screening.
    Kawamura A
    IDrugs; 2010 May; 13(5):321-4. PubMed ID: 20432189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging field of chemo- and pharmacoproteomics.
    Hess S
    Proteomics Clin Appl; 2013 Jan; 7(1-2):171-80. PubMed ID: 23184895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.